carbamates has been researched along with Hematologic Malignancies in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ganai, SA | 1 |
1 review available for carbamates and Hematologic Malignancies
| Article | Year |
|---|---|
Histone deacetylase inhibitor givinostat: the small-molecule with promising activity against therapeutically challenging haematological malignancies.
Topics: Antineoplastic Agents; Carbamates; Hematologic Neoplasms; Histone Deacetylase Inhibitors; Hodgkin Di | 2016 |